GLOBAL ACADEMY of WOMEN’S CANCER · 15:15–15:35 Endocrine sensitive metastatic Breast Cancer...
7
24/25 APRIL 2020 VIENNA INTERCONTINENTAL ® WIEN JOHANNESGASSE 28 1030 VIENNA, AUSTRIA GLOBAL ACADEMY of WOMEN’S CANCER EUROPEAN MEETIN G Simply the Best Education you can get PRELIMINARY PROGRAMME (updated: 18/12/2019)
Transcript of GLOBAL ACADEMY of WOMEN’S CANCER · 15:15–15:35 Endocrine sensitive metastatic Breast Cancer...
24/25 APRIL
2020VIENNA
INTERCONTINENTAL® WIEN JOHANNESGASSE 28
1030 VIENNA, AUSTRIA
GLOBAL ACADEMY of WOMEN’S CANCER
E U R O P E A N M E E T I N G Simply the Best Education you can get
P R E L I M I N A R Y P R O G R A M M E (updated: 18/12/2019)
Friday, April 24th
P R O G R A M M E A T A G L A N C E
8:00
9:00
10:00
11:00
12:00
13:00
14:00
15:00
16:00
17:00
KEYNOTE LECTURESwith Speakers Corner
KEYNOTE LECTURESwith Speakers Corner
KEYNOTE LECTURESwith Speakers Corner
CASE DISCUSSION
SATELLITE SYMPOSIUM I
18:00
19:00
BREAK
BREAK
2
DEBATES
R O O M P L A N
P R O G R A M M E A T A G L A N C E
Saturday, April 25th
KEYNOTE LECTURESwith Speakers Corner
JOINT LECTURE
MEET THE PROFESSORS
SATELLITE SYMPOSIUM II
SATELLITE SYMPOSIUM III
BREAK
BREAK
BREAK
10:00
11:00
12:00
13:00
14:00
15:00
16:00
17:00
18:00
19:00
8:00
9:00
3
R O O M P L A N
CASE DISCUSSION
DEBATES
4
12:00–13:00 KEYNOTE LECTURES with Speakers CornerCHAIRPERSONS: PETER SCHMID, LONDON, UNITED KINGDOM
JAVIER CORTÈS, BARCELONA, SPAIN
12:00–12:20 Adjuvant endocrine therapy – For how long? (Including bone health) Michael Gnant, Vienna, Austria
12:30–12:50 De-escalating systemic treatment strategies in early Breast Cancer – what makes sense? (Molecular profiling, HER2+, pathCR) Sherko Kümmel, Essen, Germany
13:00–14:00 KEYNOTE LECTURES with Speakers CornerCHAIRPERSONS: NICOLETTA COLOMBO, MILAN, ITALY
ALEXANDER REINTHALLER, VIENNA, AUSTRIA
13:00–13:20 How to incorporate PARP inhibitors into frontline treatment of advanced Ovarian Cancer Jonathan Ledermann, London, United Kingdom
13:30–13:50 How should patients with recurrent Ovarian Cancer previously treated with PARP inhibitors be treated? Antonio Gonzalez-Martin, Madrid, Spain
14:00–14:15 BREAK
14:15–15:15 SATELLITE SYMPOSIUM I
15:15–16:15 KEYNOTE LECTURES with Speakers CornerCHAIRPERSONS: SHERKO KÜMMEL, ESSEN, GERMANY
SARA A. HURVITZ, LOS ANGELES, USA
15:15–15:35 Endocrine sensitive metastatic Breast Cancer (treatment sequence, CDK4/6, PI3K- incl. resistance) Stephen Johnston, London, United Kingdom
15:45–16:05 Immuno-oncology in Breast Cancer – Where we are & where should we go? Peter Schmid, London, United Kingdom
Friday, April 24th
P R O G R A M M E
5
R O O M P L A N
Friday, April 24th
P R O G R A M M E
16:15–16:45 BREAK
16:45–18:15 CASE DISCUSSION CHAIRPERSON: CARLOS BARRIOS, PORTO ALGRE, BRAZIL
16:45–17:05 De-escalation in Breast and Axilla surgery – What is the right way? Jens Blohmer, Berlin, Germany
17:08–17:28 ER + MBC after CDK4/6 treatment beyond progression in EBC and MBC Stephen Johnston, London, United Kingdom
17:31–17:51 TNBC – rapidly evolving management (AKT, ADCs, DDR, CIT which sequence) Javier Cortès, Barcelona, Spain
17:54–18:14 Rare diseases Rupert Bartsch, Vienna, Austria
18:15–19:00 DEBATES MODERATOR: JONATHAN LEDERMANN, LONDON, UNITED KINGDOM
Every patient with Ovarian Cancer should receive HRD testing in addition to BRCA testing
Pro: Christian Marth, Innsbruck, Austria David Tan, Singapore
Contra: Mansoor Raza Mirza, Copenhagen, Denmark Andreas du Bois, Essen, Germany
6
Saturday, April 25th
08:00–08:30 MEET THE PROFESSORS New definitions for platinum sensitivity and resistance in Ovarian Cancer clinical practice Jonathan Ledermann, London, United KingdomImmunotherapy in recurrent Endometrial Cancer speaker invitedHow to build up an excellence program for Ovarian Cancer surgery (structures, quality assessment and blood, sweat, and tears) Andreas du Bois, Essen, GermanyManaging the side-effects of new drugs including immuno-oncology Peter Schmid, London, United KingdomManaging the side-effects of endocrine therapy Michael Gnant, Vienna, Austria
08:30–10:00 SATELLITE SYMPOSIUM II
10:00–10:15 BREAK
10:15–11:15 KEYNOTE LECTURES with Speakers CornerCHAIRPERSONS: DAVID TAN, SINGAPORE
ANTONIO GONZALEZ-MARTIN, MADRID, SPAIN
10:15–10:35 The role of surgery for recurrent OC after DESKTOP and GOG 213 Andreas du Bois, Essen, Germany
10:45–11:05 HIPEC: ready for primetime or more (and better designed) studies? Mansoor Raza Mirza, Copenhagen, Denmark
11:15–12:45 CASE DISCUSSION CHAIRPERSONS: ANDREAS DU BOIS, ESSEN GERMANY
SPEAKER INVITED
11:15–11:35 Management of Endometrial Cancer low stage (FIGO I) but at high risk (tumorbiology) Alain Zeimet, Innsbruck, Austria
11:38–11:58 Is there still a role for neoadjuvant therapy in Cervical Cancer following the EORTC and Asian trials? David Tan, Singapore
12:01–12:21 Management of a patient with an asymptomatic rise in CA 125 during maintenance therapy Stephan Polterauer, Vienna, Austria
12:24–12:45 A case about fertility preserving strategies in ovarian malignancies Nicoletta Colombo, Milan, Italy
P R O G R A M M E
7
Saturday, April 25th
12:45–13:15 BREAK
13:15–14:45 SATELLITE SYMPOSIUM III
14:45–15:30 DEBATES MODERATOR: PETER SCHMID, LONDON, UNITED KINGDOM
Should all patients with early TNBC receive platinum-based therapy: yes or no?
Yes: Javier Cortès, Barcelona, Spain
No: Sara A. Hurvitz, Los Angeles, USA
15:30–15:45 BREAK
15:45–17:15 CHAIRPERSONS: MICHAEL GNANT, VIENNA, AUSTRIA SPEAKER INVITED
JOINT LECTURETranslational research in Breast Cancer – What should we know? Speaker invited
Future Research Directions – Where do we go …
… in Gynaecological Oncology?Ovarian Cancer Philipp Harter, Essen, GermanyNon-Ovarian-Cancer Isabelle Ray-Coquard, Lyon, France
… in Breast Cancer? Carlos Barrios, Porto Alegre, Brazil
Farewell Message
R O O M P L A N
Photos: Title – istock/Meinzahn, P4 istock/vichie81, P5 istock/Anton Aleksenko, P6 istock/adisa, P7 shutterstock/RossHelen
P R O G R A M M E
